MEDINDIA
English
हिन्दी
Español
français
中文
As rated by investigators, eighty-three percent of patients treated withthe Condition & Enhance System and botulinum toxin type A injections (i.e.,Botox(R)) experienced a 1-grade improvement (from moderate to mild or mild tonone) in hyperpigmentation. Additionally, 33 percent of subjects achieved a2-grade improvement (from severe to mild or moderate to none) in this type ofsun damage related discoloration. Similar levels of improvement were alsoseen in tactile roughness and sallowness. These results are independent ofthe effects of botulinum toxin type A, therefore supporting the benefit ofusing the unique Condition & Enhance System in order to provide a morebalanced overall aesthetic result.
The 4% hydroquinone-based skin care program, known commercially as theObagi(R) Condition & Enhance System, helps correct premature photoaged skinand prevent future skin damage. The system is comprised of products that worktogether to improve overall skin health and appearance. The Condition &Enhance System, utilizing Obagi's Penetrating Therapeutics(TM), includescleanser, toner, 4% hydroquinone, exfoliant, and sunscreen SPF 35 for completeskin care.
"Using the Condition & Enhance System, with 4% hydroquinone, improvesoverall skin quality and is an effective adjunct to both non-surgical andsurgical facial rejuvenation procedures," said Jody Comstock, MD, SkinSpectrum, Tucson, AZ, and lead investigator. "With continued advances intechnology, the number of cosmetic dermatology procedures is on the rise andit is important to have a safe, effective skin care regimen to complementthese procedures and address total skin rejuvenation and the maintenance ofskin improvement."
Of the more than 2,500 patients assessed in the study, 52 percent had non-ablative/non-surgical procedures such as botulinum toxin type A injections,intense pulsed light therapy, and filler injections, while 46 percent hadablative/surgical procedures such as laser therapy, chemical peels, andsurgery. Patients used the Condition & Enhance System in conjunction withtheir facial rejuvenation procedure to enhance their overall aesthetic result.Mean duration of use of the Condition & Enhance System in this study was 4weeks pre-conditioning and 6 weeks post-conditioning.
The order and frequency of application of Condition & Enhance arecarefully defined and managed by the physician to create a 4-step process forimproving and restoring overall skin quality. The first step is skinpreparation, the second step is skin correction, the third step is skinstimulation, and the fourth step is skin protection.
"The results of this large-scale study reinforce the efficacy andtolerability of Condition & Enhance, and we are pleased to provide a systemthat works in concert with some of today's most sought-after facialrejuvenation procedures to help improve clinical outcomes," said SteveCarlson, President & CEO, Obagi Medical Products, Inc.
About Obagi Medical Products, Inc.
Obagi Medical Products develops and commercializes skin health productsfor the dermatology, plastic surgery, and related aesthetic markets. Using itsPenetrating Therapeutics(TM) technologies, Obagi Medical's products aredesigned to improve penetration of agents across the skin barrier for commonand visible skin conditions in adult s
